StonvexLoading…
StonvexStonvexStonvexWhat you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
Real-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-13 | $26.34 | $23.39 | -11.20% | 12.4M |
| 05-14 | $18.26 | $18.01 | -1.37% | 25.5M |
| 05-15 | $17.95 | $18.97 | +5.68% | 12.4M |
| 05-18 | $18.99 | $19.58 | +3.11% | 7.4M |
| 05-19 | $19.80 | $19.26 | -2.73% | 5.8M |
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Annual 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $644.86M | $499.49M | $314.44M | $145.91M |
Operating Income | $214.92M | $190.09M | $118.20M | $54.52M |
Net Income | $196.05M | $176.94M | $115.38M | $53.32M |
EPS (Diluted) | $0.98 | $0.88 | $0.57 | $0.27 |
Total Assets | $1.12B | $1.16B | $1.26B | $1.20B |
Total Liabilities | $172.85M | $177.73M | $161.58M | $178.85M |
Cash & Equivalents | $219.18M | $64.84M | $169.25M | $137.26M |
Free Cash Flow OCF − CapEx | $326.46M | Not available | Not available | Not available |
Shares Outstanding | 183.06M | 184.99M | 188.09M | 187.45M |
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.